available data – Page 28 – Communicable Diseases Research

The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis

Public Health

Published on 2021-03-052022-10-31
Journal: Frontiers in Public Health [Category] COVID-19,

Clinical presentation of COVID-19 – a model derived by a machine learning algorithm

Article

Published on 2021-03-042022-10-30
Journal: Journal of Integrative Bioinformatics [Category] Coronavirus, SARS,

Impact of contact tracing on COVID-19 mortality: An impact evaluation using surveillance data from Colombia

Research Article

Published on 2021-03-042022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

A Two-Phase Stochastic Dynamic Model for COVID-19 Mid-Term Policy Recommendations in Greece: A Pathway towards Mass Vaccination

Article

Published on 2021-03-032022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

신장 및 간 장애 환자의 용도 변경 COVID-19 약물 투여에 대한 권장 사항

Review

Published on 2021-03-012022-09-11
Journal: Drugs in R&D [Category] MERS, 신약개발, 임상, 치료제,

[키워드] acute infection acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect Altered Anakinra anticipated Antiviral Atazanavir available data Azithromycin clinician complex coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient Dexamethasone Dosing drug drug concentration drug concentrations drug interaction Efficacy excretion experimental drug Experimental drugs Favipiravir Guidance hepatic hepatic disease hepatic function hepatic impairment Hydroxychloroquine immune indications Injury interferon beta Limited Lopinavir Lopinavir/ritonavir medication medications metabolism outbreak Patient patients with COVID-19 pharmacokinetic pharmacokinetics produced recommendation reduced regimen Remdesivir renal renal or hepatic impairment respiratory resulting ribavirin Ritonavir sarilumab SARS-CoV-2 significantly therapy Tocilizumab toxicities Toxicity treat Treatment treatment for COVID-19 Trial University of Liverpool Variability was performed website
[DOI] 10.1007/s40268-020-00333-0 PMC 바로가기 [Article Type] Review

Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis

코로나19 및 암 환자의 임상적 특성 및 결과: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-03-012022-09-12
Journal: Clinical oncology (Royal College of Radiologists ( [Category] SARS, 진단,

[키워드] 95% confidence interval addition available data Cancer cancer patient Cancer patients Care changes in Chest China clinical Clinical characteristics co-morbidity computer tomography conducted country COVID-19 database Dyspnoea Evidence Fever Ground glass opacity heart hospitalised patient in-hospital mortality inflammatory markers iterative medRxiv Mortality NIH non-specific outcome oxygen saturation patients with COVID-19 performance status Prevalence primary cancer question random-effects meta-analyses review risk risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection susceptibility Symptom systematic review therapeutic interventions with COVID-19
[DOI] 10.1016/j.clon.2020.11.006 PMC 바로가기 [Article Type] Meta-Analysis

Face Masks and the Cardiorespiratory Response to Physical Activity in Health and Disease

안면 마스크와 건강 및 질병의 신체 활동에 대한 심폐 반응

Review

Published on 2021-03-012022-09-11
Journal: Annals of the American Thoracic Society [Category] SARS, 치료기술,

[키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 added Affect Alter applied available data Blood breathing Cardiopulmonary cardiopulmonary disease center changes in Control coronavirus coronavirus disease COVID-19 disease control Dyspnea Effect effort Evidence Exercise capacity Exercise Tolerance expressed face Face mask Face masks Gas exchange Health Organization healthy individuals in healthy individual individual limitation Mask Masks N95 respirators Novel coronavirus parameter physical activity physiological physiological response physiological responses prevention pulmonary limitations to exercise. Respirator respirators Respiratory mechanics Respiratory system response responsible SARS-CoV-2 severe acute respiratory syndrome Coronavirus significantly Support surgical Tolerance Transmission unlikely wearing face mask Work of breathing World Health Organization
[DOI] 10.1513/AnnalsATS.202008-990CME PMC 바로가기 [Article Type] Review

How did governmental interventions affect the spread of COVID-19 in European countries?

Research Article

Published on 2021-02-262022-10-28
Journal: BMC Public Health [Category] COVID-19, MERS,

Spatial temporal distribution of COVID-19 risk during the early phase of the pandemic in Malawi

Epidemiology

Published on 2021-02-242022-10-28
Journal: PeerJ [Category] COVID-19,

DETECT Schools Study Protocol: A Prospective Observational Cohort Surveillance Study Investigating the Impact of COVID-19 in Western Australian Schools

DETECT 학교 연구 프로토콜: 서호주 학교에서 COVID-19의 영향을 조사하는 예비 관찰 코호트 감시 연구

Observational Study

Published on 2021-02-222022-09-11
Journal: Frontiers in Public Health [Category] MERS, 임상, 진단, 치료기술,

[키워드] Asymptomatic attack rate available data balance child health children clinical close contact Community COVID-19 COVID-19 case COVID-19 pandemic determine enhanced First wave Follow-up Impact incidence individual mental health mind module not significant pandemic parent peace potential risk Prospective prospective observational cohort registration number roll SARS-CoV-2 SARS-CoV-2 testing SARS-CoV-2 transmission SARS-CoV-2 virus School Schools Screening secondary attack rate Surveillance survey the SARS-CoV-2 virus Transmission Transmission dynamics Trial Registration Number wellbeing while
[DOI] 10.3389/fpubh.2021.636921 PMC 바로가기 [Article Type] Observational Study